Skip to content

effect of herbal formulation on knee joint pain

Effect of polyherbal formulation in the treatment of Osteoarthritis Knee Joint: a randomized single blind standard controlled trial.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/05/018972
Enrollment
40
Registered
2019-05-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M170- Bilateral primary osteoarthritis of knee

Interventions

Intervention1: Polyherbal formulation.: Majoon (semi-solid) in which Haleela Zard 70 gram Suranjan 10.05gram Bozidan 10.05gram

Sponsors

Sayyed Abuzar Gaffari
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with primary osteoarthritis, fulfilling the ACR clinical/radiological classification criteria. Patients of both genders between the age group of 35 to 65 years.

Exclusion criteria

Exclusion criteria: Patients suffering with other forma of arthritis like, rheumatoid arthritis, rheumatic arthritis, psoriatic arthritis, ankylosing spondylitis gouty arthritis, infective arthritis, and systemic lupus erythematous (SLE). • Patients suffering from systemic diseases, like diabetes, endocrinal disorders, malignancies etc. • Patients with BMI >=30. Patients giving the History of recent accident or trauma. Patients with severe restricted mobility. Pregnant and lactating mothers. Sever Hb%

Design outcomes

Primary

MeasureTime frame
reducing the pain from baseline to the end of treatment.Timepoint: 30 days

Secondary

MeasureTime frame
reducing the WOMAC score and improving the quality of life and also to assess its effect on other subjective parameters from baseline to end of treatment.Timepoint: 21 days

Countries

India

Contacts

Public Contactarshid iqbal wani

Luqman Unani Medical College Hospital and Research Centre

arshidwani456@gmail.com9742863126

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026